Colby Strong

To survey patients after successful treatment, researchers developed a prediction model for recurrent dysplasia after eradication of Barrett esophagus.

Investigators assessed the benefit of a potential living donor on survival in patients with hepatocellular carcinoma on a waiting list for a liver transplant.

A team of investigators conducted a meta-analysis to assess outcomes following Helicobacter pylori eradication therapy as first-line treatment for patients with H pylori-negative gastric MALT lymphoma.